Citation

Chavers S, Fife D, Wacholtz M, Stang P, Berlin J. Pharmacoepidemiol. Drug Saf. 2011; 20(10): 1009-1013.

Affiliation

Johnson & Johnson Pharmaceutical Research and Development, L.L.C-Epidemiology, Titusville, NJ, USA. schavers@its.jnj.com.

Copyright

(Copyright © 2011, John Wiley and Sons)

DOI

10.1002/pds.2221

PMID

21953845

Abstract

Registration of randomized clinical trials has become standard practice and is enforced through publication policies and governmental regulations. However, the registration of observational studies remains controversial. In this commentary, we propose that a compromise can be reached on which observation should be registered based on study design and study intent. Copyright © 2011 John Wiley & Sons, Ltd.

Language: en